GENET-news articles on GE rabbits
2010-10-20 | permalink
Pharming (Netherlands) to sell drug from GE rabbits
Pharming, based in the Netherlands, is set to be the world’s first pharmaceutical group to derive a medicine from transgenic rabbits, using the milk they produce as the basis for its drug to treat a rare genetic disease. It will be only the second medicine cleared by regulators from a transgenic animal, after GTC Biotherapeutics of the US received authorisation to produce its ATryn drug, to prevent blood clots, from the milk of genetically modified goats.
Overview
2010-10-20 | permalink
Pharming (Netherlands) to sell drug from GE rabbits
Pharming, based in the Netherlands, is set to be the world’s first pharmaceutical group to derive a medicine from transgenic rabbits, using the milk they produce as the basis for its drug to treat a rare genetic disease. It will be only the second medicine cleared by regulators from a transgenic animal, after GTC Biotherapeutics of the US received authorisation to produce its ATryn drug, to prevent blood clots, from the milk of genetically modified goats.
